FDA Inspection 1251377 — Staska Pharmaceuticals, Inc.
The FDA completed an inspection of Staska Pharmaceuticals, Inc. on Sep 18, 2024 in Bennet, NE. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 18, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bennet, NE (United States)